# STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma

> **NCT03113955** · NA · COMPLETED · sponsor: **Varian Medical Systems** · enrollment: 109 (actual)

## Conditions studied

- Localized Hepatocellular Carcinoma

## Interventions

- **DEVICE:** Tandem Microsphere loaded with Epirubicin

## Key facts

- **NCT ID:** NCT03113955
- **Lead sponsor:** Varian Medical Systems
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-24
- **Primary completion:** 2019-06-28
- **Final completion:** 2020-02-28
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2021-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03113955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03113955, "STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03113955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*